Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00013000 · ClinicalTrials.gov registry record · NA
A Multi-Site Study of Strategies for Implementing Schizophrenia Guidelines
A NA study of Schizophrenia, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- NA
- Development phase
- 400
- Enrollment target
- 6
- Study locations
NCT00013000: Completed NA study of Schizophrenia, sponsored by US Department of Veterans Affairs.
NCT00013000 is a NA study of Schizophrenia that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 400 participants, above the 218-participant average among 315 other Schizophrenia trials with a reported enrollment target (83% higher). The trial reports 6 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00013000, a NA study of Schizophrenia, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
- 6
- Study locations
Study Summary
Schizophrenia, a chronic psychiatric disorder, is the second most frequent VA discharge diagnosis. Medication management practices for schizophrenia often are not guideline-concordant and place patients at risk for adverse outcomes. This project tests a new strategy to standard implementation for VHA Schizophrenia Guidelines.
Conditions Studied
Interventions
- BEHAVIORAL Test strategy for implementation guideline
Study Locations (6)
Texas
- VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX - Dallas
- Michael E. DeBakey VA Medical Center, Houston, TX - Houston
- South Texas Health Care System, San Antonio, TX - San Antonio
District of Columbia
- Washington DC VA Medical Center, Washington, DC - Washington D.C.
Louisiana
- Southeast Louisiana Veterans Health Care System, New Orleans, LA - New Orleans
Maryland
- Tuscaloosa VA Medical Center, Tuscaloosa, AL - Tuscaloosa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Est. Completion | 2000-09 |
| Phase | NA |
What the finished NCT00013000 record still lists
NCT00013000 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, above the 218-participant average among 315 other Schizophrenia trials with a reported enrollment target (83% higher).
The record links to 1 condition, with Schizophrenia appearing as the primary indexed condition, and to 1 intervention - of which Test strategy for implementation guideline is the first listed.
NCT00013000 lists 6 locations in 4 states (Texas, District of Columbia, Louisiana).
Frequently Asked Questions
What is clinical trial NCT00013000 about?
NCT00013000 is a clinical study titled "A Multi-Site Study of Strategies for Implementing Schizophrenia Guidelines". Schizophrenia, a chronic psychiatric disorder, is the second most frequent VA discharge diagnosis. Medication management practices for schizophrenia often are not guideline-concordant and place patients at risk for adverse outcomes. This project tests a new strategy to standard implementation for VH...
What is the current status of trial NCT00013000?
This trial is currently completed. It is a NA study. The enrollment target is 400 participants. Estimated completion is 2000-09.
What conditions does trial NCT00013000 study?
This clinical trial studies the following conditions: Schizophrenia.
What interventions are being tested in trial NCT00013000?
The interventions under investigation include: Test strategy for implementation guideline (BEHAVIORAL).
Who is sponsoring clinical trial NCT00013000?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00013000 being conducted?
This trial has 6 study locations across District of Columbia, Louisiana, Maryland, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Schizophrenia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00013000's enrollment target sits among peer trials
400 43rd of 315 higher than 271 of 315 other Schizophrenia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Schizophrenia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Taking Action for College Students
RECRUITING · NA
-
Enhancing Prefrontal Oscillations and Working Memory in Early-course Schizophrenia
RECRUITING · NA
-
Getting Out of the House: Using Behavioral Activation to Increase Community Participation
RECRUITING · NA
-
Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 1)
RECRUITING · NA
-
Cerebellar Modulation of Cognition in Psychosis
RECRUITING · NA
-
TMS for Inhibition Enhancement in Schizophrenia
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository